Stegnar, Mojca
Mojca Stegnar
VIAF ID: 220654970 ( Personal )
Permalink: http://viaf.org/viaf/220654970
Preferred Forms
- 100 0 _ ‡a Mojca Stegnar
- 100 1 _ ‡a Stegnar, Mojca
-
- 100 1 _ ‡a Stegnar, Mojca
- 100 1 _ ‡a Stegnar, Mojca
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Determination of D-dimer by different quantitative assays - a harmonization exercise | |
Eighteenth International Congress on Thrombosis | |
Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women | |
The influence of patient's age on correction of excessive anticoagulation | |
The influence of thrombin inhibitor synthons on thrombin amidolytic activity | |
Laboratory aspects of venous thrombosis | |
Markers of hemostatic system activation during treatment of deep vein thrombosis with subcutaneous unfractionated or low-molecular weight heparin | |
Mild hyperhomocysteinemia and fibrinolytic factors in patients with history o venous thromboembolism | |
New trends in classification, monitoring and management of cardiovascular diseases : handbook | |
Občutljivost nekaterih testov strjevanja krvi na antifosfolipidna protitelesa | |
Ocena uporabnosti obposteljnega določanja aktiviranega parcialnega tromboplastinskega časa pri bolnikih, zdravljenih s heparinom = Evaluation of activated of partial thromboplastin time determination by point of care method for the patients, treated with heparin : diplomska naloga | |
Određivanje koncentracije D-dimera različitim kvantitativnim testovima... | |
Of the plasminogen activator inhibitor-1 gene and its plasma levels in deep vein thrombosis | |
Overall haemostasis potential in patients with venous thrombosis before, during and after anticoagulant treatment | |
Plasminogen activator inhibitor-1 response to a carbohydrate meal in obese subjects | |
Polymorphism of beta fibrinogen gene (G/A-455) and plasma fibrinogen level in Slovenian healthy population | |
Prepoznavanje motenj hemostaze z laboratorijskimi metodami | |
Prepoznavanje trombofilije - Zakaj? Pri kom? Kako? Kdaj? = Diagnostics of thrombophilia - Why? Whom to test? How? When? | |
Primerjava učinkov antagonistov fibrinogenskega receptorja na čas krvavitve in agregacijo trombocitov = Comparison of effects of fibrinogen receptor antagonists time and platelet aggregaion : diplomska naloga | |
Raztapljanje strdkov "ex vivo" s tkivnim aktivatorjem plazminogena, streptokinazo in urokinazo = Dissolution of "ex vivo" thrombi by plasminogen activator, streptokinase and urokinase | |
Relationship between lupus anticoagulants and antiphospholipid antibodies detected by enzyme-linked immunosorbent assay | |
Reproducibility of fibrinolytic response to venous occlusion in healthy subjects | |
Research in fibrinolysis and proteolysis is focusing on extracellular matrix degradation and vascular biology | |
Research on causes of hyperhomocysteinemia in patients with chronic renal failure | |
Resistance to antiplatelet therapy in cardiovascular disease | |
The role of homocysteine in the development of vascular disease | |
Screening for serine proteinase inhibitors in extracts of mushrooms | |
Searching for selective inhibitors of thrombin and pancreactic lipase with bacterial random peptide display library and insolation of thrombin inhibitors from selected basidiomycetes | |
Seasonal fluctuation of haemostatic and metabolic variables in patients after acute myocardial infarction | |
Seasonal variation of coronary risk factors in survivors of myocardial infarction and in healthy subjects | |
Selective peptidomimetic thrombin inhibitors incorporating weakly basic partially saturated heterobicyclic P1 arginine mimetics | |
Shift work and circadian rhythm of blood fibrinolytic parameters | |
Slovenska raziskava o preprečevanju ishemičnih zapletov pri bolnikih s periferno arterijsko boleznijo - 2-letni rezultati raziskave PIB-PAB | |
Spremembe hemostaze v starosti | |
SRCE IN OZILJE : LETNO POROCILO. | |
Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors | |
Suitability of selected clotting assays to explain anitithrombotic potential of LK732, argatroban and nadroparin in rat venous thrombosis model | |
Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitors | |
Synthesis of 1,2,4-oxadiazole-based peptidomimetics as potential GPIIb/III antagonists | |
Thrombin inhibitors built on an azaphenylalanine scaffold | |
Thrombin inhibitors : European Patent Number: EP1287018B1 : International publication number: WO2001/085760 | |
Thrombin inhibitors : patent : US 7524871 (B2), 2009-04-29 | |
Thrombin inhibitors : publication number US 2005/0165034 A1 (28.7.2005) : application number 10/497,328 | |
Thrombophilic markers frequency in the patients with deep venous thrombosis | |
Tissue plasminogen activator release in chronic venous hypertension due to heart failure | |
Tromboza in arterioskleroza. | |
Ugotavljanje jakosti potencialnih inhibitorjev trombina z amidolitično metodo in in vitro na človeški plazmi = Evaluation of potency of potential thrombin inhibitors by amidolytic method and in vitro in human plasma : diplomska naloga : graduation thesis | |
Uporabnost amidolitične encimske metode za merjenje učinkovitosti inhibitorjev na trombin vezan v strdku : [magistrska naloga] | |
Uravnavanje fibrinolitične aktivnosti krvi: vloga maščevja | |
Utility of PFA-100((R)) closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro | |
Validation of an automated immunoturbidimetric assay for measurement of plasmaD-dimer | |
Variation in platelet function testing has a major influence on detection of aspirin resistance in healthy subjects | |
Venous thromnoembolism associated polymorphisms in Slovene population | |
Venska tromboza in pljučna embolija | |
VPLIV DIHIDROERGOTOKSINA (REDERGINA) NA AGREGACIJO TROMBOCITOV IN FIBRINOLIZO PRI BOLNIKIH Z ARTEROSKLEROZO. | |
Vpliv genskih polimorfizmov na tveganje in zdravljenje žilnih bolezni : doktorska disertacija | |
Vpliv hujšanja in vzdrževanja telesne teže na fibrinolitično aktivnost krvi pri premenopavzalnih ženskah : magistrsko delo | |
Vpliv pH citratne plazme na določanje fibrinolitičnih spremenljivk | |
Vpliv polimorfizmov v genih za alfa in beta fibrinogen na nivo fibrinogena v plazmi | |
Vpliv predanalitskih dejavnikov na agregacijo trombocitov = The influence of preanalytical variables on platelet aggregation : diplomska naloga | |
Vpliv zgodnje ambulantne rehabilitacije po srčnem infarktu. Merjenje hitrosti toka krvi v vratnih arterijah z doplersko ultrazvočno metodo. Dnevno nihanje tkivnega aktivatorja plazminogena v krvi. Fibrolitični potencial zgornjih okončin pri ročnih delavcih. Vpliv hipoksije na sproščanje aktivatorja plazminogena v mirovanju in ob fizičnem naporu. Saturacija z medigoksinom v krvi pri starejših bolnikih. | |
Vrednotenje biološke učinkovitosti potencialnih antagonistov GP IIb/IIIa receptorja = Evaluation of biological efficacy of potential antagonists of GP IIb/IIIa receptor : diplomska naloga | |
What to expect from prevention cardiovascular disease in patients with peripheral arterial disease | |
Whole blood agglutination assay for D-dimer in diagnostics of deep vein thrombosis of the limbs |